A global scientific strategy to cure hepatitis B.

Details

Serval ID
serval:BIB_BCB3A34F7D9D
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
A global scientific strategy to cure hepatitis B.
Journal
The lancet. Gastroenterology & hepatology
Author(s)
Revill P.A., Chisari F.V., Block J.M., Dandri M., Gehring A.J., Guo H., Hu J., Kramvis A., Lampertico P., Janssen HLA, Levrero M., Li W., Liang T.J., Lim S.G., Lu F., Penicaud M.C., Tavis J.E., Thimme R., Zoulim F.
Working group(s)
Members of the ICE-HBV Working Groups, ICE-HBV Stakeholders Group Chairs, ICE-HBV Senior Advisors
Contributor(s)
Arbuthnot P., Boonstra A., Chang K.M., Chen P.J., Glebe D., Guidotti L.G., Fellay J., Ferrari C., Jansen L., Lau DTY, Lok A.S., Maini M.K., Mason W., Matthews G., Paraskevis D., Petersen J., Rehermann B., Shin E.C., Thompson A., van Bömmel F., Wang F.S., Watashi K., Yang H.C., Yuan Z., Yuen M.F., Block T., Miller V., Protzer U., Bréchot C., Locarnini S., Peters M.G., Schinazi R.F.
ISSN
2468-1253 (Electronic)
Publication state
Published
Issued date
07/2019
Peer-reviewed
Oui
Volume
4
Number
7
Pages
545-558
Language
english
Notes
Publication types: Journal Article ; Research Support, N.I.H., Intramural
Publication Status: ppublish
Abstract
Chronic hepatitis B virus (HBV) infection is a global public health challenge on the same scale as tuberculosis, HIV, and malaria. The International Coalition to Eliminate HBV (ICE-HBV) is a coalition of experts dedicated to accelerating the discovery of a cure for chronic hepatitis B. Following extensive consultation with more than 50 scientists from across the globe, as well as key stakeholders including people affected by HBV, we have identified gaps in our current knowledge and new strategies and tools that are required to achieve HBV cure. We believe that research must focus on the discovery of interventional strategies that will permanently reduce the number of productively infected cells or permanently silence the covalently closed circular DNA in those cells, and that will stimulate HBV-specific host immune responses which mimic spontaneous resolution of HBV infection. There is also a pressing need for the establishment of repositories of standardised HBV reagents and protocols that can be accessed by all HBV researchers throughout the world. The HBV cure research agenda outlined in this position paper will contribute markedly to the goal of eliminating HBV infection worldwide.
Keywords
Animals, Antiviral Agents/therapeutic use, B-Lymphocytes/immunology, Cell Line, Transformed, DNA, Viral/drug effects, Disease Eradication/methods, Disease Models, Animal, Forecasting, Global Health, Hepatitis B virus/immunology, Hepatitis B virus/physiology, Hepatitis B, Chronic/immunology, Hepatitis B, Chronic/prevention & control, Hepatitis B, Chronic/virology, Hepatocytes/virology, Humans, Immunity, Cellular, Immunotherapy/methods, Immunotherapy/trends, Liver Neoplasms/prevention & control, Remission Induction, Research, T-Lymphocytes/immunology, Virus Replication/physiology
Pubmed
Web of science
Open Access
Yes
Create date
13/09/2020 13:39
Last modification date
10/10/2023 6:01
Usage data